We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Corrigendum to "OAB-005: Update of safety and efficacy of Isatuximab short-duration fixed-volume infusion plus Bortezomib, Lenalidomide, and Dexamethasone combined therapy for NDMM ineligible/with no immediate intent for ASCT" [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S3-S4]
- Authors
Ocio, Enrique M.; Perrot, Aurore; Bories, Pierre; San-Miguel, Jesùs F.; Blau, Igor W.; Karlin, Lionel; Martinez-Lôpezl, Joaquin; Pönisch, Wolfram; Bringhen, Sara; Marcatti, Magda; Mateos, Maria-Victoria; Rodriguez-Oterol, Paula; LeRouxi, Nadia; Dong, Yvonne; Macé, Sandrine; Fitzmaurice, Thomas; Moreau, Philippe
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2022, Vol 22, Issue 6, p425
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2022.03.010